Read the latest MS news

Get up to date with all the latest MS news on research, treatments and campaigning. And find out what we're doing together to stop MS.

Add bookmark

News

Over a third of people with MS have avoided seeking medical help due to embarrassment

This year’s MS Awareness week campaign is called MS Unfiltered. It aims to shine a light on the MS topics that can feel taboo or difficult to talk about. As part of this, we teamed up with other MS charities to survey over 1,400 people with MS about their experiences.

New rights for carer’s leave

This week, the Carer’s Leave Act became UK law, bringing in new rights for unpaid carers who work.

Make sure your candidate speaks up for MS: tips from Charlotte Nichols MP

MP for Warrington North, Charlotte Nichols, joined us for our campaign training session on influencing decision makers.

MS Society election manifesto launched in parliament

With an election on the horizon, this week we launched our manifesto at the AGM of the All-Party Parliamentary Group (APPG) for MS.

Have you checked if you’re eligible to vote in the UK general election?

A general election is expected to take place this year. Here’s what you need to know if you want to vote.

New research reveals the power of microglia in smouldering MS

The brain’s resident immune cells are in overdrive in MS. New research has identified one potential reason why. And, how the cells could be controlled.

Funding for the future: why investing in MS now saves money later

Many of us were disappointed by today’s Budget, and its lack of investment for NHS neurological services. This feels like a missed opportunity.

New genetics research could help diagnose MS earlier

Researchers have developed a way to predict whether people with optic neuritis will go on to be diagnosed with MS.

New insights into risk of MS in people living with HIV

A study of health information from people who are living with HIV and taking antiviral treatments showed they had a reduced risk of developing MS.

New research with ancient human DNA shows the origins of MS risk genes

An international collaboration of researchers has shown genes linked to MS may have evolved as a way to protect against infections.

Phase 3 trials show evobrutinib is no better than existing treatments for people with relapsing MS

Pharmaceutical company Merck announced the results of the EVOLUTION (evolutionRMS1 and evolutionRMS2) clinical trials earlier this month. They found evobrutinib wasn’t more effective at reducing relapses than existing drug teriflunomide.

New research shows dose of cladribine treatment may predict risk of future relapses and lesions

Researchers in London have found that new disease activity after treatment with cladribine could be connected to two factors before, and during treatment.

Introducing Platypus – the Australian extension of our Octopus trial

People with progressive MS in Australia now have the chance to join Platypus – an extension of the Octopus trial.

Early research trials stem cell injection into brains of people with MS

A phase I clinical trial in Italy showed a technique to deliver stem cells directly into the brain was feasible and safe for a small group of people with secondary progressive MS.

What does the UK Government’s Autumn Statement mean for people with MS?

One of the key announcements from the Autumn Statement is the changes to the Work Capability Assessment. Read how this may impact people with MS.

New research shows AI may help doctors interpret MRI scans more accurately

Researchers have now found artificial intelligence (AI) may help detect changes on MRI scans more accurately.

Soul music singer Junior Giscombe announced as our new Ambassador

We’re excited to announce Grammy award-winning artist Junior Giscombe as our newest Ambassador

U-turn on railway ticket office closures

We're delighted to share that the Government has made a U-turn on plans to close railway ticket offices across England.

World-first clinical trial for advanced MS: hundredth participant joins ChariotMS

Tina Morris is the hundredth person to join ChariotMS, our phase 2 trial testing whether cladribine can help people with MS maintain the use of their arms and hands.

Thousands tell the UK Government to fix PIP now

On Wednesday 25 October we delivered our #10YearsOfPIP petition to the Department of Work and Pensions.

About us

We’re the MS Society – a community of people living with MS, scientists, campaigners, volunteers and fundraisers.

We understand what life’s like with MS, and we support each other through the highs, lows and everything in between.

And we’re driving research into more – and better – treatments. For everyone.

Together, we are strong enough to stop MS.

Learn more about us